News|Articles|March 24, 2005

Warning Letter: Germiphene

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Fresenius Kabi and Phlow Corp. Collaboration | Created with Canva

Fresenius Kabi and Phlow Corp. Enter First US End-to-End Manufacturing Collaboration

ByZachary Zubulake

February 9th 2026

Women in STEM: Early Phase Drug Development

BySusan Haigney

February 6th 2026

Male red plastic toy businessman silhouette | Image Source: ©H_Ko -stock.adobe.com

Rare Disease Treatments: Navigating the Economics of Global Innovation

ByNathan Edwards, PhD

February 5th 2026

Women in STEM: Cultivating Scientific Confidence

BySusan Haigney

February 4th 2026

Shaping the Future of Microbial Development: From Gene to GMP

ByFUJIFILM Biotechnologies

February 4th 2026

Warning Letter: Germiphene

Newsletter

Related Content

Fresenius Kabi and Phlow Corp. Enter First US End-to-End Manufacturing Collaboration

Women in STEM: Early Phase Drug Development

Rare Disease Treatments: Navigating the Economics of Global Innovation

Women in STEM: Cultivating Scientific Confidence

Shaping the Future of Microbial Development: From Gene to GMP

Trending on Pharmaceutical Technology

Hovione’s Strategy for Complexity, Speed, and Regional Supply Chains

FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B

PharmTech Weekly Roundup - February 6, 2026

Fresenius Kabi and Phlow Corp. Enter First US End-to-End Manufacturing Collaboration

Rare Disease Treatments: Navigating the Economics of Global Innovation